According to Zhitong Finance App, Haofan Biotech (301393.SZ) released its report for the first quarter of 2024. During the period, the company achieved operating income of 91,2297 million yuan, a year-on-year decrease of 27.14%; net profit attributable to shareholders of listed companies was 298.288 million yuan, a year-on-year decrease of 17.8%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 257.698 million yuan, a year-on-year decrease of 24.12%; basic earnings per share were 0.28 yuan/share.